Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Other Non-Current Assets (2022 - 2026)

Kura Oncology has reported Other Non-Current Assets over the past 5 years, most recently at $14.0 million for Q1 2026.

  • Quarterly Other Non-Current Assets rose 54.09% to $14.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $14.0 million through Mar 2026, up 54.09% year-over-year, with the annual reading at $14.5 million for FY2025, 85.38% up from the prior year.
  • Other Non-Current Assets was $14.0 million for Q1 2026 at Kura Oncology, down from $14.5 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $14.5 million in Q4 2025 and troughed at $210000.0 in Q1 2023.
  • The 5-year median for Other Non-Current Assets is $7.8 million (2024), against an average of $8.0 million.
  • The largest YoY upside for Other Non-Current Assets was 3550.48% in 2024 against a maximum downside of 3.2% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $3.5 million in 2022, then surged by 117.32% to $7.6 million in 2023, then grew by 3.2% to $7.8 million in 2024, then skyrocketed by 85.38% to $14.5 million in 2025, then decreased by 3.8% to $14.0 million in 2026.
  • Per Business Quant, the three most recent readings for KURA's Other Non-Current Assets are $14.0 million (Q1 2026), $14.5 million (Q4 2025), and $13.8 million (Q3 2025).